Paul E. Alexander
#52,705
Most Influential Person Now
Canadian health researcher
Paul E. Alexander's AcademicInfluence.com Rankings
Paul E. Alexanderphilosophy Degrees
Philosophy
#7818
World Rank
#11077
Historical Rank
Logic
#9661
World Rank
#12275
Historical Rank

Download Badge
Philosophy
Why Is Paul E. Alexander Influential?
(Suggest an Edit or Addition)According to Wikipedia, Paul Elias Alexander is a Canadian independent scientist, and a former Trump administration official at the U.S. Department of Health and Human Services during the COVID-19 pandemic. Alexander was recruited from his part-time, unpaid position at McMaster University to serve as an aide to HHS assistant secretary for public affairs Michael Caputo in March 2020. In that role, Alexander pressured federal scientists and public health agencies to suppress and edit their COVID-19 analyses to make them consistent with Trump's rhetoric.
Paul E. Alexander's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) (2020) (1956)
- Drug treatments for covid-19: living systematic review and network meta-analysis (2020) (557)
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (2020) (456)
- Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. (2018) (334)
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. (2018) (287)
- Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia (2015) (250)
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. (2019) (248)
- Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline (2020) (148)
- Decision aids for localized prostate cancer treatment choice: Systematic review and meta‐analysis (2015) (125)
- A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. (2016) (119)
- COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine (2020) (112)
- Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. (2016) (108)
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis (2021) (93)
- Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). (2020) (68)
- World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. (2016) (62)
- Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis (2016) (62)
- World Health Organization recommendations are often strong based on low confidence in effect estimates. (2014) (60)
- High statistical heterogeneity is more frequent in meta-analysis of continuous than binary outcomes. (2016) (59)
- GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings. (2021) (58)
- A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. (2016) (48)
- Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta‐analysis (2017) (44)
- Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. (2020) (41)
- GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist. (2017) (38)
- Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol (2013) (31)
- Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review (2020) (30)
- Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey. (2018) (25)
- UpToDate adherence to GRADE criteria for strong recommendations: an analytical survey (2017) (23)
- Evidence to Decision framework provides a structured "roadmap" for making GRADE guidelines recommendations. (2018) (23)
- GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines (2021) (21)
- Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study (2014) (17)
- Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis (2017) (17)
- Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis (2021) (15)
- Reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials : a systematic survey (2017) (14)
- Senior GRADE methodologists encounter challenges as part of WHO guideline development panels: an inductive content analysis. (2016) (14)
- Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient‐important outcomes (2018) (13)
- Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for COPD: A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline. (2020) (13)
- Sensitivity subgroup analysis based on single-center vs. multi-center trial status when interpreting meta-analyses pooled estimates: the logical way forward. (2016) (13)
- Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis. (2013) (12)
- How to use a patient management recommendation : : clinical practice guidelines and decision analyses (2014) (11)
- Applying GRADE to a network meta-analysis of antidepressants led to more conservative conclusions. (2018) (10)
- Triple Therapy versus Dual or Monotherapy with Long-acting Bronchodilators for COPD: A Systematic Review and Meta-Analysis. (2020) (10)
- Canadian Primary Care Physicians' Attitudes Toward Understanding Clinical Practice Guidelines for Diabetes Screening. (2016) (8)
- Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data. (2019) (8)
- Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents (2021) (7)
- A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials. (2017) (7)
- Structured decision-making drives guidelines panels' recommendations "for" but not "against" health interventions. (2019) (6)
- P1_185 The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: a Systematic Review and Meta-Analysis (2017) (5)
- Corrigendum to "Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis" [J Clin Epidemiol 2018;93:36-44]. (2018) (5)
- Patients’ values and preferences of the expected efficacy of hip arthroscopy for osteoarthritis: a protocol for a multinational structured interview-based study combined with a randomised survey on the optimal amount of information to elicit preferences (2014) (5)
- A highly structured decision-making process results in GRADE factors having primary influence on how guidelines panels develop clinical recommendations (2019) (4)
- Summary for Clinicians: Clinical Practice Guideline on Pharmacologic Management of Chronic Obstructive Pulmonary Disease. (2020) (2)
- SP125THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS (2017) (2)
- Interferon-β-1a for patients with moderate to severe acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. (2020) (2)
- Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details (2021) (1)
- Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents (2021) (1)
- MP42-19 DECISION AIDS FOR LOCALIZED PROSTATE CANCER TREATMENT CHOICE: SYSTEMATIC REVIEW AND META-ANALYSIS (2015) (1)
- How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations (2018) (0)
- How to Use EBM/GRADE to Develop Guidelines (2018) (0)
- 747. Antibiotic Therapy for Community-Acquired Pneumonia: A Systematic Review and Network Meta-Analysis of Randomized Trials (2018) (0)
- CLINICAL PRACTICE AND PUBLIC HEALTH GUIDELINES: THE MAKING OF APPROPRIATE STRONG RECOMMENDATIONS WHEN THE CONFIDENCE IN EFFECT ESTIMATES IS LOW OR VERY LOW (DISCORDANT) (2015) (0)
- The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines (2018) (0)
- Reply to: Opioids for Dyspnea in COPD: Short on the Details. (2020) (0)
This paper list is powered by the following services:
Other Resources About Paul E. Alexander
What Schools Are Affiliated With Paul E. Alexander?
Paul E. Alexander is affiliated with the following schools: